Baldwin Investment Management, LLC Astrazeneca PLC Transaction History

Baldwin Investment Management, LLC

$388 Million
Q3 2024

A detailed history of Baldwin Investment Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Baldwin Investment Management, LLC holds 4,656 shares of AZN stock, worth $312,883. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,656

Previous 4,656 -0.0%

Holding current value

$312,883

Previous $363,000 0.28%

% of portfolio

0.09%

Previous 0.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$66.81 - $80.83 $6,681 - $8,083	-100 Reduced 2.1%	4,656 $363,000
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $12,206 - $13,913	-200 Reduced 4.04%	4,756 $322,000
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $6,484 - $7,170	-100 Reduced 1.98%	4,956 $335,000
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $10,604 - $27,150	-200 Reduced 3.81%	5,056 $277,000
Q2 2022 Aug 02, 2022	SELL	$59.26 - $71.14 $35,556 - $42,684	-600 Reduced 10.25%	5,256 $347,000
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $2,786 - $3,356	-50 Reduced 0.85%	5,856 $388,000
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $2,778 - $3,039	50 Added 0.85%	5,906 $355,000
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $4,852 - $5,802	-100 Reduced 1.68%	5,856 $293,000
Q3 2019 Nov 13, 2019	BUY	$40.12 - $45.47 $10,270 - $11,640	256 Added 4.49%	5,956 $265,000
Q2 2019 Aug 06, 2019	BUY	$37.28 - $41.68 $3,728 - $4,168	100 Added 1.79%	5,700 $235,000
Q4 2018 Feb 13, 2019	BUY	$36.86 - $41.49 $3,686 - $4,149	100 Added 1.82%	5,600 $213,000
Q3 2018 Nov 09, 2018	BUY	$34.76 - $39.72 $191,180 - $218,460	5,500 New	5,500 $218,000

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Investment Management, LLC with notifications on news.

Account

Baldwin Investment Management, LLC Astrazeneca PLC Transaction History